Stocks in Focus on April 30, 2021: IP and ATP30

Kaohoon Online has selected stocks with a high-growth potential for investors to consider on April 30, 2021.

 

Finansia Syrus Securities (FSS) has given a “BUY” recommendation on Interpharma Public Company Limited (IP) with a target price at ฿27.00/share.

FSS expected IP to record 1Q21 profit growth of 432% QoQ and 73% over the same period last year after recognizing a full-quarter revenue from the merging of Modern Pharma and utilized full production capacity, more rebranding and marketing, while the heavily advertised IP’s Probac Fit and PreBO last quarter showed its results.

Outlook for the second half of 2021 is growing strongly from the integration of Teva factories. FSS adjusted the profit in 2021-2025 by an average of 15% per year, while recording a 105% growth this year.

 

Maybank Kim Eng has given a “Speculative BUY” recommendation on ATP30 Public Company Limited (ATP30) with a target price at ฿1.40/share.

Maybank revised up ATP30 earnings in 2021 by 22% to 73.6% YoY, expecting strong growth in 1Q21 earnings by 97.4% YoY after the joining with Toyotetsu (Thailand) Co., Ltd. (TTTH) resulted in a faster negotiation and settling the deal with foreign customers. More importantly, ATP30 expected to close the deal with one major customer in Japan, which would result in an expansion of its fleet by 18%. In addition, Maybank believed there would be more deals and opportunities from joining TTTH.